Some view the COVID-19 pandemic as a reputational turning point for pharma and an opportunity to solidify a more positive impact on society. Many pharmaceutical companies are furthering this goal by incorporating ESG into their operations.
Recognizing an increasing risk in younger adults, the U.S. Preventive Services Task Force updated its guidelines in 2021, lowering the recommended screening start age from 50 to 45.
joint efforts will form best practices for non-profit health organizations to leverage patient self-reporting with the goal of advancing science, treatment and quality of life.
The term CovIdiot is misleading as it suggests anti-vax and anti-pandemic people are idiots. Nothing could be further from the truth and this perception prevents us reaching this demographic.